Estrella Immunopharma, Inc. (ESLA) stock
ESLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLAW
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.33−0.05 (-12.74%)
Close on Nov 17, 2026Market cap $14.42MP/E –Yield –
Estrella Immunopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Estrella Immunopharma's enterprise value was $21.42M on Nov 11, 2026, against $73.08M a year earlier. Over the last 5 years it ranged from $1.79M to $84.43M, with a median of $25.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.42M | -59.5% |
| 2025 | Dec 31, 2025 | $52.95M | +33.1% |
| 2024 | Dec 31, 2024 | $39.77M | +134.8% |
| 2023 | Dec 29, 2023 | $16.94M | +19.9% |
| 2022 | Dec 30, 2022 | $14.13M | +6.3% |
| 2021 | Dec 31, 2021 | $13.30M | – |
See a number that looks wrong?